Gain deep insights into companies, competitors, and market trends to drive smarter business growth and success.

CIREX PHARMACEUTICALS PRIVATE LIMITED

Active

CIREX PHARMACEUTICALS PRIVATE LIMITED having CIN U24239TG1990PTC012119 is 34 years , 5 month & 20 days old Private Indian Company incorporated on 21 Dec 1990. It is classified as Non-government company and is registered at ROC Hyderabad. Its authorized share capital is Rs. 50,000,000 and its paid up capital is Rs. 41,503,500. It's NIC code is 24239 (which is part of its CIN).

As per the NIC code, it is involved in Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc. . CIREX PHARMACEUTICALS Annual General Meeting (AGM) was last held on N/A and as per records from Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 09-14-2023. Directors of CIREX PHARMACEUTICALS are Navin kumar reddy Puchakayala and Gopalakrishna Chittajallu.

CIREX PHARMACEUTICALS ' Corporate Identification Number (CIN) is U24239TG1990PTC012119 and its registration number is 012119. Users may contact CIREX PHARMACEUTICALS on its Email address - cirex.secretarial@gmail.com Registered address of CIREX PHARMACEUTICALS is H.NO. 8-3-166/7/1, ERRAGADDA,HYDERABAD,Telangana,India-500018. Current status of CIREX PHARMACEUTICALS PRIVATE LIMITED is - Active.

Key Indicators

Authorised Capital
50,000,000

as on 10/06/2025

Paid Up Capital
41,503,500

as on 10/06/2025

Company Age
34 Year, 5 Months
Last Filing with ROC
1 Year, 8 Months

Company Information

CIN U24239TG1990PTC012119
Company Status Active
Registration Number 012119
Date of Incorporation 12/21/1990
RoC ROC Hyderabad
Company Age 34 years & 180 days
Authorized Capital ₹ 50000000
Paid-up capital ₹ 41503500
Company Category Company limited by shares
Company Sub-Category Non-government company
Class of company Private
Activity Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc.
Listing status Unlisted
Date of Last Annual General Meeting 31-03-2023
Date of Latest Balance Sheet 31-03-2023

Contact

Email ID cirex.secretarial@gmail.com
Address 7-2-A2, HETERO CORPORATE INDUSTRIAL ESTATE, SANATHNAGAR HYDERABAD Andhra Pradesh India 500018
Website ********.com
Contact Number +91*******

Location on Map

Director

Designation Name Date OF Appointment DIN PAN Tenure
Director
GOPALAKRISHNA CHITTAJALLU
07/14/2023 07757879 1 years
Director
CHANDRA SEKHAR TUMULURU
03/17/2023 07212178 *****9324Q 2 years
Director
NAVIN KUMAR REDDY PUCHAKAYALA
02/06/2023 09184037 2 years

Companies connected through Directors

Name Status Paid Up Capital Common Directors Address
WALLET PHARMA PRIVATE LIMITED
Active
98,00,00,000.00 2 Telangana
EVARIC PHARMA PRIVATE LIMITED
Strike Off
1,00,000.00 2 Telangana
ACTERO PHARMA PRIVATE LIMITED
Active
1,00,000.00 2 Telangana
GLENYS LAB PRIVATE LIMITED
Strike Off
20,00,000.00 2 Telangana
HETERO LIFE SCIENCES PRIVATE LIMITED
Active
1,00,000.00 2 Telangana
HETERO MARBLES PRIVATE LIMITED
Active
1,00,000.00 2 Telangana
HETERO PLASMA SCIENCES PRIVATE LIMITED
Active
40,01,00,000.00 1
INVAGEN PHARMACEUTICALS PRIVATE LIMITED
Strike Off
1,00,000.00 2 Telangana
HETERO BIOPHARMA LIMITED
Active
1,50,05,00,000.00 2 Telangana
STRIVO PHARMA PRIVATE LIMITED
Active
6,00,000.00 2 Telangana
VEER EAST REALTY INDIA PRIVATE LIMITED
Active
13,77,82,950.00 2 Telangana
HOSTER LABS PRIVATE LIMITED
Active
1,01,00,000.00 2 Telangana
SVS DRUGS AND PHARMACEUTICALS PVT LTD
Active
4,21,000.00 2 Telangana
ANNORA PHARMA PRIVATE LIMITED
Active
2,86,00,00,000.00 2 Telangana
ASPIRO PHARMA LIMITED
Active
2,54,14,60,000.00 2 Telangana
SELMAR LAB PRIVATE LIMITED
Active
4,51,69,050.00 2 Telangana

Charges on assets

1

STATE BANK OF HYDERABAD

No. of Loans: 2

Total Amount: 1,085,000,000.00 cr

2

Andhra Pradesh State Financial Corporation

No. of Loans: 1

Total Amount: 6,220,000.00 cr

3

INDIAN OVERSEAS BANK

No. of Loans: 1

Total Amount: 500,000.00 cr

4

AP STATE FINANCIAL CORPORATION

No. of Loans: 1

Total Amount: 5,580,000.00 cr

Charge Holder Branch Amount Date of creation Modification Satisfaction Status
STATE BANK OF HYDERABAD 740,000,000 21 May, 2009 29 Apr, 2014 03 Dec, 2015 Closed
Andhra Pradesh State Financial Corporation Hyderabad 6,220,000 22 Mar, 1991 - 06 May, 2014 Closed
STATE BANK OF HYDERABAD SANATHNAGR 345,000,000 09 Feb, 2001 22 Dec, 2007 03 Dec, 2015 Closed
INDIAN OVERSEAS BANK PAIGA PLAZA BUILDING ;BASHERBAGH BUILDING 500,000 29 Mar, 1995 23 Dec, 1995 11 Mar, 1999 Closed
AP STATE FINANCIAL CORPORATION 5,580,000 20 Mar, 1995 20 Mar, 1995 15 May, 1999 Closed

Registered Details

CIN
U24239TG1990PTC012119
PAN
U24239TG1990PTC012119
Incorporation
2 years , 4 month
Company Email
cirex.secretarial@gmail.com
Paid up Capital
₹ 41,503,500
Authorised Capital
₹ 50,000,000
Type
Private Non-government company

* There is the date provided by MCA, but availability for this year is not guaranteed.

-

Industry

Manufacture Of Other Pharmaceutical And Botanical Products Like Hina Powder Etc.

Key Metrics

** All rupee values in INR crores. Based on March 2024 numbers.

Sales arrow 9.29%
₹ 140,987.4
EBITDA arrow 29%
₹ 135,987.4
Net Profit arrow 29%
₹ 135,987.4
Networth arrow 29%
₹ 135,987.4
Borrowings arrow 9.29%
₹ 140,987.4
Assets arrow 9.29%
₹ 140,987.4
Gross Margin arrow 9.29%
₹ 140,987.4
Operating Margin arrow 29%
₹ 135,987.4
Net Profit Margin arrow 29%
₹ 135,987.4
Return on Equity arrow 29%
₹ 135,987.4
ROCE arrow 9.29%
₹ 140,987.4
Debt to Equity arrow 9.29%
₹ 140,987.4

Financial Highlights

** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Sales Locked Locked Locked Locked Locked
Operating profit Locked Locked Locked Locked Locked
Net profit Locked Locked Locked Locked Locked
Gross margin Locked Locked Locked Locked Locked
Operating margin Locked Locked Locked Locked Locked
Net margin Locked Locked Locked Locked Locked
Networth Locked Locked Locked Locked Locked
Borrowings Locked Locked Locked Locked Locked
Assets Locked Locked Locked Locked Locked
Debt to equity Locked Locked Locked Locked Locked
Current ratio Locked Locked Locked Locked Locked
ROE Locked Locked Locked Locked Locked
Days payable Locked Locked Locked Locked Locked
WC days Locked Locked Locked Locked Locked
unlock

Subscribe to access detailed insight of companies

subscribe

Balance Sheet

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + Locked Locked Locked Locked Locked
(a) Share capita Locked Locked Locked Locked Locked
(b) Reserves and surplus Locked Locked Locked Locked Locked
(c) Money received against share warrants Locked Locked Locked Locked Locked
(2) Share application money pending allotment Locked Locked Locked Locked Locked
(3) Non-current liabilities + Locked Locked Locked Locked Locked
(a) Long-term borrowings Locked Locked Locked Locked Locked
(b) Deferred tax liabilities (Net) Locked Locked Locked Locked Locked
(c) Other Long-term liabilities Locked Locked Locked Locked Locked
(d) Long-term provisions Locked Locked Locked Locked Locked
(4) Current liabilities + Locked Locked Locked Locked Locked
(a) Short-term borrowings Locked Locked Locked Locked Locked
(b) Trade payables Locked Locked Locked Locked Locked
(A) total outstanding dues of micro enterprises and small enterprises; and Locked Locked Locked Locked Locked
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. Locked Locked Locked Locked Locked
(c) Other current liabilities Locked Locked Locked Locked Locked
(d) Short-term provisions Locked Locked Locked Locked Locked
Total Locked Locked Locked Locked Locked
ASSETS
Non-current assets + Locked Locked Locked Locked Locked
(a) [Property, Plant and Equipment] Locked Locked Locked Locked Locked
(i) Tangible assets Locked Locked Locked Locked Locked
(ii) Intangible assets Locked Locked Locked Locked Locked
(iii)Capital work-in-progress Locked Locked Locked Locked Locked
(iv) Intangible assets under development Locked Locked Locked Locked Locked
(b) Non-current investments Locked Locked Locked Locked Locked
(c) Deferred tax assets (net) Locked Locked Locked Locked Locked
(d) Long-term loans and advances Locked Locked Locked Locked Locked
(e) Other non-current assets Locked Locked Locked Locked Locked
(2) Current assets + Locked Locked Locked Locked Locked
(a) Current investments Locked Locked Locked Locked Locked
(b) Inventories Locked Locked Locked Locked Locked
(c) Trade receivables Locked Locked Locked Locked Locked
(d) Cash and cash equivalents Locked Locked Locked Locked Locked
(e) Short-term loans and advances Locked Locked Locked Locked Locked
(f) Other current assets Locked Locked Locked Locked Locked
Total assets Locked Locked Locked Locked Locked
Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
EQUITY AND LIABILITIES
(1) Shareholders‘ funds + lock lock lock lock lock
(a) Share capita lock lock lock lock lock
(b) Reserves and surplus lock lock lock lock lock
(c) Money received against share warrants lock lock lock lock lock
(2) Share application money pending allotment lock lock lock lock lock
(3) Non-current liabilities + lock lock lock lock lock
(a) Long-term borrowings lock lock lock lock lock
(b) Deferred tax liabilities (Net) lock lock lock lock lock
(c) Other Long-term liabilities lock lock lock lock lock
(d) Long-term provisions lock lock lock lock lock
(4) Current liabilities + lock lock lock lock lock
(a) Short-term borrowings lock lock lock lock lock
(b) Trade payables lock lock lock lock lock
(A) total outstanding dues of micro enterprises and small enterprises; and lock lock lock lock lock
(B) total outstanding dues of creditors other than micro enterprises and small enterprises. lock lock lock lock lock
(c) Other current liabilities lock lock lock lock lock
(d) Short-term provisions lock lock lock lock lock
Total lock lock lock lock lock
ASSETS
Non-current assets + lock lock lock lock lock
(a) [Property, Plant and Equipment] lock lock lock lock lock
(i) Tangible assets lock lock lock lock lock
(ii) Intangible assets lock lock lock lock lock
(iii)Capital work-in-progress lock lock lock lock lock
(iv) Intangible assets under development lock lock lock lock lock
(b) Non-current investments lock lock lock lock lock
(c) Deferred tax assets (net) lock lock lock lock lock
(d) Long-term loans and advances lock lock lock lock lock
(e) Other non-current assets lock lock lock lock lock
(2) Current assets + lock lock lock lock lock
(a) Current investments lock lock lock lock lock
(b) Inventories lock lock lock lock lock
(c) Trade receivables lock lock lock lock lock
(d) Cash and cash equivalents lock lock lock lock lock
(e) Short-term loans and advances lock lock lock lock lock
(f) Other current assets lock lock lock lock lock
Total assets lock lock lock lock lock

Profit & Loss

**** All numbers in INR crores

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
I.Revenue from operations lock lock lock lock lock
II. Other income lock lock lock lock lock
III.Total Revenue (I + II) lock lock lock lock lock
IV.Expenses + lock lock lock lock lock
(1)Cost of materials consumed lock lock lock lock lock
(2)Purchases of Stock-in-Trade lock lock lock lock lock
(3)Changes in inventories of finished goods work-in-progress and lock lock lock lock lock
(4)Stock-in-Trade lock lock lock lock lock
(5)Employee benefits expense lock lock lock lock lock
(6)Finance costs lock lock lock lock lock
(7)Depreciation and amortisation expense lock lock lock lock lock
(8)Other expenses lock lock lock lock lock
(9)Total expenses lock lock lock lock lock
VProfit before exceptional and extraordinary items and tax (III - IV) lock lock lock lock lock
VIExceptional items lock lock lock lock lock
VII.Profit before extraordinary items and tax (V - VI) lock lock lock lock lock
VIII.Extraordinary items lock lock lock lock lock
IX.Profit before tax (VII- VIII) lock lock lock lock lock
X. Tax expense: + lock lock lock lock lock
(1)Current tax lock lock lock lock lock
(2)Deferred tax lock lock lock lock lock
XI.Profit (Loss) for the period from continuing operations (VII-VIII) lock lock lock lock lock
XII.Profit/(loss) from discontinuing operations lock lock lock lock lock
XIII.Tax expense of discontinuing operations lock lock lock lock lock
XIV.Profit/(loss) from Discontinuing operations (after tax) (XII-XIII) lock lock lock lock lock
XV.Profit (Loss) for the period (XI + XIV) lock lock lock lock lock
XVI.Earnings per equity share: + lock lock lock lock lock
(1) Basic lock lock lock lock lock
(2)Diluted lock lock lock lock lock
Precentage of total incomex
Sales +
Sales growth %
Expenses +
Cost of services
Employee benefits expense
Other costs
Operating profit + lock lock lock
Operating margin % lock lock lock
Other income
Interest lock lock lock
Depreciation lock lock lock
Exceptional items
Profit before tax
Tax lock lock lock
Profit - disc. ops lock lock lock
Net profit lock lock lock
Net margin % lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Ratio

** All numbers in INR crores
Solvency +
Total Debt/Equity
Net Debt/Equity lock lock lock
Total Debt/Assets
Total Assets/Equity
Liquidity +
Current Ratio
Quick Ratio
Interest Coverage
Performance lock lock lock
Gross Margin
Operating Margin
Net Margin
Return + lock lock lock
Return on Equity
Pre-tax ROCE lock lock lock
Return on Assets lock lock lock
Pre-tax ROIC lock lock lock
Efficiency + lock lock lock
Days Payable lock lock lock
Days Inventory lock lock lock
Days Receivable lock lock lock
Fixed Asset Turnover lock lock lock
Total Asset Turnover lock lock lock
Working Capital lock lock lock
Cash Conversion Cycle lock lock lock
Working Capital Days lock lock lock
unlock

Subscribe to access detailed insight of companies

subscribe

Subsidiaries, Associate Companies & Join Ventures of Cirex Pharmaceuticals Private Limited

Company Identifier Name Percentage of Shares Held
lock lock lock
lock lock lock
lock lock lock

Fund Raising Activity of Cirex Pharmaceuticals Private Limited

Date of Allotment Securities Alloted Terms Number of Securities Nominal Amount Premium Amount Due & Payable Premium Amount Paid Total Discount Amount to be Paid on Calls (Excluding Premium) Attachments
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock lock

Board Meetings of Cirex Pharmaceuticals Private Limited

Date of Filing Date of Dispatch of Notice Date of Passing Resolution Section (Companies Act 2013) Section (Companies Act 1956) Subject Matter of Resolution Resolution Agreed By Resolution Type Additional Documents
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock
lock lock lock lock lock lock lock lock lock

Auditors of Cirex Pharmaceuticals Private Limited

Financial Year Name of Auditor or Firm PAN of Auditor or Firm Membership Number / Registration Number Name of Auditor Signing Report Membership Number of Auditor Signing Report
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Outstanding Payments to Micro & Small Enterprises

Filing Type As On Amount Due to MSME Current Liabilities Ratio to Current Liabilities Reasons for Delay
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

Investor Complaints & Serious Complaints About Cirex Pharmaceuticals Private Limited

Director Complain

Date DIN Cessation Date Cessation Reason Complaint
lock lock lock lock lock
lock lock lock lock lock
lock lock lock lock lock

Serious Complaints

Date Complaint Other
lock lock lock
lock lock lock
lock lock lock

Investor Complaints & Other Complaints

Date Complaint Type Complaint Sub Type Particulars of Secutiries Period Complaint Other Details
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock
lock lock lock lock lock lock lock

Prosecution Details of Cirex Pharmaceuticals Private Limited

S.No. Defaulting Entities Court Name Prosecution Section Date of Order Status
lock lock lock lock lock lock
lock lock lock lock lock lock
lock lock lock lock lock lock

FAQs- Cirex Pharmaceuticals Private Limited

What is CIREX PHARMACEUTICALS PRIVATE LIMITED ?

CIREX PHARMACEUTICALS PRIVATE LIMITED having CIN U24239TG1990PTC012119 is 2 years , 4 month old Private Indian Company incorporated with MCA on 06 Feb 2023. CIREX PHARMACEUTICALS PRIVATE LIMITED is listed in the class of Private Indian Company and classified as Non-government company. This company is registered at Registrar of Companies(ROC), ROC Hyderabad with an Authorized Share Capital of 50,000,000 and paid-up capital is 41,503,500.

What is the CIN of CIREX PHARMACEUTICALS PRIVATE LIMITED?

CIN of CIREX PHARMACEUTICALS PRIVATE LIMITED is U24239TG1990PTC012119.

Where is CIREX PHARMACEUTICALS PRIVATE LIMITED located?

Address of CIREX PHARMACEUTICALS PRIVATE LIMITED is H.no. 8-3-166/7/1, erragadda,hyderabad,telangana,india-500018,.

Who are the directors of CIREX PHARMACEUTICALS PRIVATE LIMITED ?

The company has 6 directors/key management personnel Gopalakrishna Chittajallu,chandra Sekhar Tumuluru,navin Kumar Reddy Puchakayala,navin Kumar Reddy Puchakayala,chandra Tumuluru,gopalakrishna Chittajallu,

What is the contact details of CIREX PHARMACEUTICALS PRIVATE LIMITED ?

Email : cirex.secretarial@gmail.com
Address : 7-2-A2, HETERO CORPORATE INDUSTRIAL ESTATE, SANATHNAGAR HYDERABAD Andhra Pradesh India 500018

What does CIREX PHARMACEUTICALS PRIVATE LIMITED do?

CIREX PHARMACEUTICALS PRIVATE LIMITED is involved in activities such as Computer programming, consultancy and related activities

Popular Services

Spice Board registration APEDA Registration Importer Exporter Code Registration AD Code Registration ESI Registration FSSAI Registration FCRA Registration FCRA Registration for Trusts FCRA Registration for Societies FCRA Registration for Section 8 Company Import Export Code Import Export Code Process NSIC Registration Private Limited Company Limited Liability Partnership Partnership Firm One Person Company Startup India Registration PF Registration Director KYC Auditor's Appointment Director's Appointment Net worth Certificate Labour License LLP Annual Compliance Filing

Popular Search

Top Companies in your State

Enquiry